Biogen

Sobi Takes 7 Aspaveli/Empaveli Abstracts to ASN Kidney Week

Stockholm – October 19, 2026 -- Sobi will present seven accepted abstracts on Aspaveli/Empaveli (pegcetacoplan) at the American Society of Nephrology (ASN) Kidney Week 2026, running 21–25 October in Denver, Colorado, including two oral and five poster presentations.

Oral sessions report 76-week outcomes in two rare kidney diseases

The two oral presentations cover 76-week outcomes with Aspaveli/Empaveli in C3 glomerulopathy (C3G) and primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN). According to Sobi, the data show maintained proteinuria reduction and stabilised eGFR. The package includes a paediatric subgroup analysis from the VALIANT study and its VALE extension.

Canada's Drug Agency Backs Public Reimbursement of Alzheimer's Drug Leqembi

STOCKHOLM – September 04, 2026 -- Canada's Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of Leqembi (lecanemab) for patients with mild cognitive impairment or mild dementia due to early Alzheimer's disease, BioArctic AB's partner Eisai announced.

Final recommendation follows agency reconsideration process

The decision comes after CDA-AMC reconsidered its position on the drug, marking a step toward broader patient access in Canada. Negotiations will now proceed through the pan-Canadian Pharmaceutical Alliance, followed by individual reimbursement decisions from public drug plans across Canada's provinces and territories.

PVA Gathers 400+ Clinicians in Las Vegas for SCI/MS/ALS Care Summit

Las Vegas – September 03, 2026 -- Paralyzed Veterans of America (PVA) opened its 2026 Healthcare Summit + Expo at the Horseshoe Hotel, drawing more than 400 healthcare professionals to advance clinical care for spinal cord injury, MS, and ALS. The event runs through September 2 and features 110 speakers and 60 exhibitors, with remarks from Department of Veterans Affairs Secretary Doug Collins.

Summit connects 400 clinicians to close gaps in SCI/D care

PVA National President Robert Thomas said healthcare for veterans with traumatic spinal cord injuries and diseases like MS and ALS extends from research through rehabilitation and long-term community life. PVA, founded in 1946, is the only nonprofit Veterans Service Organization with access inside all 25 VA SCI/D Centers, a position that has shaped its 80-year investment in research, clinical education, and advocacy.